CG Oncology, Inc. (CGON) bonds
CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$78.94−5.84 (-6.89%)
Close on Nov 17, 2026Market cap $7.00BP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Total debt
$3.00M
Long-term debt
Net debt
-$25.25M
After $28.25M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in CG Oncology's 10-K for the period ended Jan 31, 2021
| Issue | Amount issued |
|---|---|
| Loan Agreement with Silicon Valley Bank (SVB) | $15.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.
See a number that looks wrong?